NCT00078247View on ClinicalTrials.gov

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

October 31, 2004

Conditions
HIV InfectionsTuberculosis
Interventions
DRUG

Abacavir

300 mg tablet taken orally twice daily

DRUG

Lamivudine

300 mg tablet taken orally daily

DRUG

Zidovudine

300 mg tablet taken orally twice daily

DRUG

Tuberculosis treatment

Tuberculosis treatment

Trial Locations (1)

Unknown

Makerere University Medical School, Kampala

All Listed Sponsors
collaborator

Makerere University

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00078247 - Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis | Biotech Hunter | Biotech Hunter